Abstract
Axillary lymph node status remains an important prognostic factor in patients with breast cancer. Axillary ultrasound (AUS) is an important tool in the workup of patients with newly diagnosed breast cancer and also has an emerging role evaluating the axilla after neoadjuvant chemotherapy. This review discusses the value of AUS in the workup and management of patients with newly diagnosed breast cancer and describes its role given the recent changes in axillary management.
Original language | English (US) |
---|---|
Pages (from-to) | 634-641 |
Number of pages | 8 |
Journal | Breast Journal |
Volume | 21 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2015 |
Keywords
- axillary ultrasound
- breast cancer
- sentinel lymph node
ASJC Scopus subject areas
- Internal Medicine
- Surgery
- Oncology